Status:
COMPLETED
Behavioral Neurocardiac Training and Hypertension
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Unilever R&D
Conditions:
Hypertension
Eligibility:
All Genders
35-64 years
Phase:
NA
Brief Summary
This randomized controlled trial will examine whether behavioral neurocardiac training with heart rate variability biofeedback (BNT) augments reduction in ambulatory daytime and 24-hour SBP, DBP and P...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 35 to 64 years of age
- diagnosis of Grade 1 or 2 hypertension (140-159 mmHg or 160-180 mmHg SBP; or 90-99 or 100-110 mmHg DBP, respectively).
- among subjects not prescribed medication, hypertension confirmed by ambulatory BP monitoring: mean 24-hour SBP \> 130 mmHg or DBP \> 80 mmHg.
- subjects prescribed antihypertensive pharmacotherapy are required to have a treatment regimen that was unchanged for at least 4 months prior to enrollment.
- Exclusion criteria:
- diagnosis of cardiovascular disease, clinically significant arrhythmia, sleep disorder, psychiatric illness (eg. psychosis), alcohol/drug dependence within the previous year, or an inability to comprehend English or French
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00811811
Start Date
May 1 2005
End Date
December 1 2007
Last Update
December 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4